About

Imatinib is a groundbreaking oral tyrosine kinase inhibitor, representing a paradigm shift in targeted cancer therapy. It is primarily indicated for the treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST), conditions driven by specific molecular abnormalities. In CML, imatinib selectively inhibits the constitutively active Bcr-Abl tyrosine kinase, a fusion protein that is the hallmark of the disease and drives uncontrolled proliferation of myeloid cells. For GIST, it targets the KIT and PDGFRA receptor tyrosine kinases, which are often mutated and hyperactive in these tumors. By precisely blocking these aberrant signaling pathways, imatinib effectively halts the growth and survival of cancer cells, leading to profound and durable remissions. Its targeted mechanism allows for greater specificity against cancer cells compared to traditional chemotherapy, often resulting in a more favorable side effect profile.

Uses

Treatment of chronic myeloid leukemia (CML).
Management of gastrointestinal stromal tumors (GIST).
Therapy for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
Treatment of myelodysplastic/myeloproliferative diseases.

Directions For Use

Take orally with a meal and a large glass of water to minimize gastrointestinal irritation. Do not crush or chew the tablets.

Benefits

Highly effective in CML and GIST.
Targeted therapy with fewer systemic side effects than traditional chemo.
Significantly improves survival rates in CML.
Available in oral form for convenience.
Can induce durable remissions.
Revolutionized treatment for specific cancers.

Side Effects

Fluid retention (edema, especially periorbital)
Nausea
Vomiting
Diarrhea
Muscle cramps
Fatigue
Rash
Headache
Abdominal pain
Myelosuppression (mild to moderate)
Liver enzyme elevation
Heart failure (rare)

Safety Measures

Alcohol - Avoid or limit alcohol consumption as it may increase the risk of liver toxicity and gastrointestinal upset.
Pregnancy - Contraindicated due to potential for severe fetal harm. Effective contraception is essential during treatment.
Breastfeeding - Contraindicated. Imatinib is excreted in breast milk and can cause serious adverse effects in the infant.
Liver - Use with caution and reduce dosage in patients with liver impairment; monitor liver function tests closely.
Kidney - Use with caution in patients with severe kidney impairment; monitor renal function and electrolyte balance.
Lung - Monitor for potential pulmonary toxicity, including interstitial lung disease or pneumonitis, though rare.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.

Shipping & Location